News - Transition Therapeutics


Current filters:

Transition Therapeutics

Popular Filters

Transition in new licensing deal with Eli Lilly


Canada's Transition Therapeutics (TSX: TTH) has entered an exclusive licensing of worldwide rights to…

Anti-Arthritics/RheumaticsEli LillyLicensingPharmaceuticalTransition TherapeuticsTT-601

Eli Lilly exercises rights to diabetes drug candidate TT-401 from Transition Therapeutics


Canada's Transition Therapeutics (TSX: TTH) announced this morning (June 17) that US drug major Eli Lilly…

DiabetesEli LillyLicensingPharmaceuticalTransition TherapeuticsTT-401

Management changes at Mylan, Transition Thera, Pfizer and ShangPharma


US generic drug major Mylan (Nasdaq: MYL) has announced the appointment of John Thievon as president…

GenericsManagementMylan LaboratoriesPharmaceuticalShangPharmaTransition Therapeutics

Back to top